5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 9.31▼ | 9.33▼ | 9.33▼ | 8.83▼ | 8.71▼ |
MA10 | 10.15▼ | 9.75▼ | 9.28▼ | 8.72▼ | 8.26▲ |
MA20 | 10.23▼ | 8.86▼ | 8.47▲ | 8.53▼ | 7.99▲ |
MA50 | 9.05▼ | 8.06▲ | 7.93▲ | 7.98▲ | 8.50▼ |
MA100 | 8.37▲ | 7.93▲ | 7.89▲ | 7.83▲ | 15.49▼ |
MA200 | 8.13▲ | 8.01▲ | 8.36▲ | 8.54▼ | 207.17▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.351▼ | -0.105▼ | -0.005▼ | -0.038▼ | 0.234▲ |
RSI | 32.954▼ | 47.446▼ | 50.146▲ | 49.562▼ | 49.797▼ |
STOCH | 13.323▼ | 39.623 | 48.835 | 31.116 | 74.921 |
WILL %R | -100.000▼ | -82.111▼ | -77.994▼ | -88.694▼ | -60.977 |
CCI | -164.726▼ | -66.800 | -31.793 | -36.383 | 140.551▲ |
Friday, June 06, 2025 04:49 PM
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 6, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a ...
|
Thursday, June 05, 2025 06:00 PM
Geneva, Switzerland, June 6, 2025-Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric ...
|
Monday, June 02, 2025 10:00 PM
Geneva, Switzerland, June 3, 2025-Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 8.31 | 8.3831 | 8.31 | 8.3831 | 2,641 |
12/06/25 | 8.75 | 9.02 | 8.1136 | 8.1136 | 5,359 |
11/06/25 | 9.005 | 9.005 | 9.005 | 9.005 | 1,340 |
10/06/25 | 8.74 | 8.74 | 8.57 | 8.57 | 8,511 |
09/06/25 | 10.20 | 11.00 | 9.65 | 10.055 | 8,283 |
06/06/25 | 8.7874 | 11.31 | 8.73 | 10.227 | 51,767 |
05/06/25 | 8.28 | 8.57 | 8.28 | 8.57 | 1,259 |
04/06/25 | 8.1558 | 8.1558 | 8.1558 | 8.1558 | 814 |
03/06/25 | 8.0849 | 8.0849 | 8.08 | 8.08 | 1,001 |
02/06/25 | 8.20 | 8.20 | 8.09 | 8.09 | 477 |
|
|
||||
|
|
||||
|
|